CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Global Marketing Resources Inc

Global Marketing Resources Inc is a Dunedin, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Red Rock Behavioral Health Services

Red Rock Behavioral Health Services is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Society of Plastic Surgeons

American Society of Plastic Surgeons is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EverVet Partners

Pennsylvania Medical Society

The Pennsylvania Medical Society Alliance is an organization of physicians' spouses dedicated to the health of America.